Literature DB >> 22652667

Use of BMPs and bisphosphonates in improving bone fracture healing.

Nicole Y C Yu1, Aaron Schindeler, Magnus Tagil, Andrew J Ruys, David G Little.   

Abstract

In orthopaedics, focus is often placed on increasing bone formation by an anabolic drug like the recombinant human bone morphogenetic protein (rhBMP). However, premature or excessive bone resorption, due to stress-shielding, instability or infection/inflammation can lead to poor, delayed, or absent bone union. Anti-catabolic drugs such as bisphosphonates have therefore been explored to improve bone repair. This short review discusses the current literature underlying the anabolic-catabolic paradigm for bone repair with a focus on BMP and bisphosphonate combination approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652667     DOI: 10.2741/e572

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  8 in total

1.  Fixation stability dictates the differentiation pathway of periosteal progenitor cells in fracture repair.

Authors:  Yusuke Hagiwara; Nathaniel A Dyment; Xi Jiang; Huang Jiang Ping; Cheryl Ackert-Bicknell; Douglas J Adams; David W Rowe
Journal:  J Orthop Res       Date:  2015-05-13       Impact factor: 3.494

2.  Non-viral gene-activated matrices: next generation constructs for bone repair.

Authors:  Erica G Tierney; Garry P Duffy; Sally-Ann Cryan; Caroline M Curtin; Fergal J O'Brien
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

3.  Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.

Authors:  Yanshuai Zhang; Erin Gatenby McNerny; Masahiko Terajima; Mekhala Raghavan; Genevieve Romanowicz; Zhanpeng Zhang; Honghao Zhang; Nobuhiro Kamiya; Margaret Tantillo; Peizhi Zhu; Gregory J Scott; Manas K Ray; Michelle Lynch; Peter X Ma; Michael D Morris; Mitsuo Yamauchi; David H Kohn; Yuji Mishina
Journal:  Bone       Date:  2016-04-23       Impact factor: 4.398

4.  Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.

Authors:  Honghao Zhang; Yanshuai Zhang; Masahiko Terajima; Genevieve Romanowicz; Yangjia Liu; Maiko Omi; Erin Bigelow; Danese M Joiner; Erik I Waldorff; Peizhi Zhu; Mekhala Raghavan; Michelle Lynch; Nobuhiro Kamiya; Rongqing Zhang; Karl J Jepsen; Steve Goldstein; Michael D Morris; Mitsuo Yamauchi; David H Kohn; Yuji Mishina
Journal:  Bone       Date:  2020-05-01       Impact factor: 4.398

5.  Utilizing BMP-2 muteins for treatment of multiple myeloma.

Authors:  Axel Seher; Charlotte Lagler; Thorsten Stühmer; Urs Dietmar Achim Müller-Richter; Alexander Christian Kübler; Walter Sebald; Thomas Dieter Müller; Joachim Nickel
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

6.  Local application of ibandronate/gelatin sponge improves osteotomy healing in rabbits.

Authors:  Zongyou Yang; Wei Chen; Zhidao Xia; Yueju Liu; Shaun Peggrem; Tao Geng; Zhaoxu Yang; Han Li; Bin Xu; Chi Zhang; James T Triffitt; Yingze Zhang
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

Review 7.  Orthopaedic traumatology: fundamental principles and current controversies for the acute care surgeon.

Authors:  Shad K Pharaon; Shawn Schoch; Lucas Marchand; Amer Mirza; John Mayberry
Journal:  Trauma Surg Acute Care Open       Date:  2018-01-08

8.  Single postoperative infusion of zoledronic acid to improve patient-reported outcome after hip or knee replacement: study protocol for a randomised, controlled, double-blinded clinical trial.

Authors:  Jonathan Brandt; Håkan Ledin; Jonas Ranstam; Ewa Roos; Per Aspenberg; Jörg Schilcher
Journal:  BMJ Open       Date:  2020-09-30       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.